|
DVAX
|
US |
DYNAVAX TECHNOLOGIES CORP |
17,791,486 |
$227M |
8.47% |
42.0%
|
- |
|
GH
|
US |
GUARDANT HEALTH INC |
6,419,566 |
$196M |
7.31% |
7.0%
|
- |
|
ITCI
|
US |
INTRA-CELLULAR THERAPIES INC |
2,000,000 |
$167M |
6.23% |
24.9%
|
- |
|
IMVT
|
US |
IMMUNOVANT INC |
6,000,000 |
$149M |
5.54% |
38.0%
|
- |
|
APLS
|
US |
APELLIS PHARMACEUTICALS INC |
4,274,921 |
$136M |
5.09% |
-2.9%
|
- |
|
SWTX
|
US |
SPRINGWORKS THERAPEUTICS INC |
3,460,756 |
$125M |
4.66% |
-10.0%
|
- |
|
CYTK
|
US |
CYTOKINETICS INC |
2,500,000 |
$118M |
4.39% |
296.9%
|
- |
|
OCUL
|
US |
OCULAR THERAPEUTIX INC |
12,836,282 |
$110M |
4.09% |
0.9%
|
- |
|
VRDN
|
US |
VIRIDIAN THERAPEUTICS INC |
4,522,741 |
$87M |
3.23% |
20.6%
|
- |
|
PLRX
|
US |
PLIANT THERAPEUTICS INC |
5,972,257 |
$79M |
2.93% |
-
|
- |
|
GPCR
|
US |
STRUCTURE THERAPEUTICS INC |
2,800,000 |
$76M |
2.83% |
129.4%
|
- |
|
IONS
|
US |
IONIS PHARMACEUTICALS INC |
1,933,928 |
$68M |
2.52% |
-12.1%
|
- |
|
NRIX
|
US |
NURIX THERAPEUTICS INC |
3,000,000 |
$57M |
2.11% |
-22.4%
|
- |
|
MBX
|
US |
MBX BIOSCIENCES INC |
3,018,935 |
$56M |
2.08% |
-
|
- |
|
ETNB
|
US |
89BIO INC |
6,478,249 |
$51M |
1.89% |
134.2%
|
- |
|
HRMY
|
US |
HARMONY BIOSCIENCES HOLDINGS |
1,450,000 |
$50M |
1.86% |
100.0%
|
- |
|
DYN
|
US |
DYNE THERAPEUTICS INC |
2,000,000 |
$47M |
1.76% |
-39.1%
|
- |
|
81734D104
|
- |
SEPTERNA INC |
1,912,929 |
$44M |
1.63% |
100.0%
|
- |
|
NMRA
|
US |
NEUMORA THERAPEUTICS INC |
4,000,000 |
$42M |
1.58% |
604.9%
|
- |
|
GMAB
|
US |
GENMAB A/S -SP ADR |
2,000,000 |
$42M |
1.56% |
100.0%
|
- |